Pinealon

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) from the Khavinson class of bioregulatory peptides developed at the Saint Petersburg Institute of Bioregulation and Gerontology. It is designed to target central nervous system (CNS) tissue, particularly the pineal gland and brain cortex, through proposed peptide-DNA interactions that modulate neuronal gene expression. Pinealon is named for its association with pineal tissue, though its proposed activity extends to broader CNS biology. The Khavinson bioregulatory model proposes that Pinealon can cross cellular membranes and interact with DNA regulatory regions in neuronal cells, influencing transcription of genes involved in neuroprotection, circadian regulation, and brain tissue homeostasis. Pinealon has been investigated in Russian biogerontology research examining age-related changes in CNS function and neuronal gene expression patterns.

Pinealon has been investigated for its proposed interactions with gene regulatory regions in CNS tissue cells. The Khavinson model proposes that the Glu-Asp-Arg sequence penetrates cell membranes and interacts with specific DNA sequences in promoter regions of brain-expressed genes. Researchers have observed that Pinealon treatment in neuronal culture models was associated with changes in expression of genes involved in neuroprotection, antioxidant defense, and synaptic function. Studies from the Saint Petersburg group suggest that Pinealon may influence pineal gland function and melatonin biosynthesis regulation, similar to but distinct from Epitalon. In cortical neuron models, researchers observed effects on cellular viability markers under oxidative stress conditions. The peptide’s proposed mechanism involves direct peptide-DNA interactions and chromatin remodeling rather than conventional neurotransmitter receptor signaling, consistent with the broader Khavinson bioregulatory framework.

Neuroprotective Studies

Khavinson et al. (2011) investigated Pinealon in cortical neuron cultures and observed changes in cell viability and gene expression under oxidative stress conditions, suggesting neuroprotective properties for the tripeptide [1].

Bioregulatory Peptide Model

Khavinson VK (2002) described the comprehensive framework for CNS-targeted bioregulatory peptides including Pinealon [2].

Short Peptide Nuclear Penetration

Fedoreyeva et al. (2011) demonstrated that fluorescence-labeled short peptides can penetrate cell nuclei in culture models, supporting the proposed mechanism for CNS bioregulatory peptides [3].